Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 84, Issue 1, Pages (July 2013)

Similar presentations


Presentation on theme: "Volume 84, Issue 1, Pages (July 2013)"— Presentation transcript:

1 Volume 84, Issue 1, Pages 34-44 (July 2013)
Glomerular diseases seen with cancer and chemotherapy: a narrative review  Kenar D. Jhaveri, Hitesh H. Shah, Kellie Calderon, Eric S. Campenot, Jai Radhakrishnan  Kidney International  Volume 84, Issue 1, Pages (July 2013) DOI: /ki Copyright © 2013 International Society of Nephrology Terms and Conditions

2 Figure 1 Membranous glomerulopathy (original magnification × 600, trichrome stain). Glomerulus displaying membranous features with fuchsinophilic subepithelial deposits. The patient has a history of lung cancer with multiple enlarged hilar lymph nodes. Kidney International  , 34-44DOI: ( /ki ) Copyright © 2013 International Society of Nephrology Terms and Conditions

3 Figure 2 Original magnification × 600, hematoxylin and eosin (H&E) stain. Glomerulus displaying membranoproliferative features with accentuated lobularity, mesangial proliferation, and endocapillary proliferation. The patient has a history of chronic lymphocytic leukemia. Kidney International  , 34-44DOI: ( /ki ) Copyright © 2013 International Society of Nephrology Terms and Conditions

4 Figure 3 Collapsing focal segmental glomerulosclerosis (FSGS; original magnification × 600, Jones methenamine silver (JMS) stain). Collapsing FSGS in a patient who has a history of malignant melanoma and is being treated with interferon therapy. Kidney International  , 34-44DOI: ( /ki ) Copyright © 2013 International Society of Nephrology Terms and Conditions

5 Figure 4 Thrombotic microangiopathy (TMA; original magnification × 600, Jones methenamine silver (JMS) stain). Glomerulus displaying changes of acute thrombotic microangiopathy with red blood cell congestion, intracapillary fibrin thrombi, and mesangiolysis. The patient has a history of pancreatic cancer with liver metastasis and is being treated with tyrosine kinase inhibitors (sorafenib and erlotinib). Kidney International  , 34-44DOI: ( /ki ) Copyright © 2013 International Society of Nephrology Terms and Conditions


Download ppt "Volume 84, Issue 1, Pages (July 2013)"

Similar presentations


Ads by Google